BioStar Ventures

BioStar Capital is a Charlevoix, Michigan–based venture capital firm founded in 2005 that invests in transformative medical technologies with a primary focus on cardiovascular, orthopedic and robotics-related medical device innovation, partnering with founders and clinical teams to advance solutions addressing unmet healthcare needs. The firm combines capital with a multidisciplinary team of renowned healthcare clinicians, medical thought leaders and financial professionals to evaluate clinical significance, market potential and commercial viability across seed, early and growth stages. BioStar typically focuses on early-stage and growth financings with initial investments often between roughly $1 M and $10 M and provides operational, clinical and strategic support alongside financing. Its investment model integrates deep clinical expertise to help portfolio companies navigate development, FDA processes and commercialization pathways while fostering alignment with patient impact and investor return objectives. Over its history, BioStar has managed multiple venture funds and backed companies developing advanced medical devices, robotics and related technologies. The firm operates primarily in the United States while supporting innovations with global relevance.